Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page
- Check2 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the Record History for the study page. The previous revision, v3.5.3, is no longer current in the visible history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s displayed revision identifier changes from v3.5.2 to v3.5.3, indicating a site/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRelease note added for site version v3.5.0 in the record history. The previous version v3.4.3 was removed from the history.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded a new revision entry for v3.4.3 and removed the v3.4.2 entry in the study record's history.SummaryDifference0.1%

- Check95 days agoChange DetectedAdded revision entry v3.4.2 and removed v3.4.1 in the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.